My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 223

    1.

    Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-gamma-mediated changes in gene expression.

    Brunmair B, Gras F, Neschen S, Roden M, Wagner L, Waldhäusl W, Fürnsinn C.

    Diabetes. 2001 Oct;50(10):2309-15.PMID: 11574413 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma.

    Wang M, Wise SC, Leff T, Su TZ.

    Diabetes. 1999 Feb;48(2):254-60.PMID: 10334298 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Troglitazone directly inhibits CO(2) production from glucose and palmitate in isolated rat skeletal muscle.

    Fürnsinn C, Brunmair B, Neschen S, Roden M, Waldhäusl W.

    J Pharmacol Exp Ther. 2000 May;293(2):487-93.PMID: 10773019 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARgamma agonist) action.

    Zierath JR, Ryder JW, Doebber T, Woods J, Wu M, Ventre J, Li Z, McCrary C, Berger J, Zhang B, Moller DE.

    Endocrinology. 1998 Dec;139(12):5034-41.PMID: 9832442 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells.

    Goetze S, Xi XP, Kawano H, Gotlibowski T, Fleck E, Hsueh WA, Law RE.

    J Cardiovasc Pharmacol. 1999 May;33(5):798-806.PMID: 10226869 [PubMed - indexed for MEDLINE]Related articles

    6.

    Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-gamma (PPARgamma)-independent, antioxidant-related mechanism.

    Davies GF, Khandelwal RL, Wu L, Juurlink BH, Roesler WJ.

    Biochem Pharmacol. 2001 Oct 15;62(8):1071-9.PMID: 11597575 [PubMed - indexed for MEDLINE]Related articles

    7.

    Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle.

    Cha BS, Ciaraldi TP, Carter L, Nikoulina SE, Mudaliar S, Mukherjee R, Paterniti JR Jr, Henry RR.

    Diabetologia. 2001 Apr;44(4):444-52.PMID: 11357475 [PubMed - indexed for MEDLINE]Related articles

    8.

    Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes.

    Dello Russo C, Gavrilyuk V, Weinberg G, Almeida A, Bolanos JP, Palmer J, Pelligrino D, Galea E, Feinstein DL.

    J Biol Chem. 2003 Feb 21;278(8):5828-36. Epub 2002 Dec 16.PMID: 12486128 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Unique ability of troglitazone to up-regulate peroxisome proliferator-activated receptor-gamma expression in hepatocytes.

    Davies GF, McFie PJ, Khandelwal RL, Roesler WJ.

    J Pharmacol Exp Ther. 2002 Jan;300(1):72-7.PMID: 11752099 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells.

    Aoun P, Simpkins JW, Agarwal N.

    Invest Ophthalmol Vis Sci. 2003 Jul;44(7):2999-3004.PMID: 12824244 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Ligands of peroxisome proliferator-activated receptor-gamma block activation of pancreatic stellate cells.

    Masamune A, Kikuta K, Satoh M, Sakai Y, Satoh A, Shimosegawa T.

    J Biol Chem. 2002 Jan 4;277(1):141-7. Epub 2001 Oct 17.PMID: 11606585 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues.

    LeBrasseur NK, Kelly M, Tsao TS, Farmer SR, Saha AK, Ruderman NB, Tomas E.

    Am J Physiol Endocrinol Metab. 2006 Jul;291(1):E175-81. Epub 2006 Feb 7.PMID: 16464908 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression.

    Kelly LJ, Vicario PP, Thompson GM, Candelore MR, Doebber TW, Ventre J, Wu MS, Meurer R, Forrest MJ, Conner MW, Cascieri MA, Moller DE.

    Endocrinology. 1998 Dec;139(12):4920-7.PMID: 9832429 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Chronic and acute effects of thiazolidinediones BM13.1258 and BM15.2054 on rat skeletal muscle glucose metabolism.

    Fürnsinn C, Brunmair B, Meyer M, Neschen S, Furtmüller R, Roden M, Kühnle HF, Nowotny P, Schneider B, Waldhäusl W.

    Br J Pharmacol. 1999 Nov;128(6):1141-8.PMID: 10578125 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Differential effects among thiazolidinediones on the transcription of thromboxane receptor and angiotensin II type 1 receptor genes.

    Sugawara A, Takeuchi K, Uruno A, Ikeda Y, Arima S, Sato K, Kudo M, Taniyama Y, Ito S.

    Hypertens Res. 2001 May;24(3):229-33.PMID: 11409645 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone.

    Camp HS, Li O, Wise SC, Hong YH, Frankowski CL, Shen X, Vanbogelen R, Leff T.

    Diabetes. 2000 Apr;49(4):539-47.PMID: 10871190 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells.

    Masamune A, Satoh K, Sakai Y, Yoshida M, Satoh A, Shimosegawa T.

    Pancreas. 2002 Mar;24(2):130-8.PMID: 11854617 [PubMed - indexed for MEDLINE]Related articles

    18.

    Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats.

    Ma LJ, Marcantoni C, Linton MF, Fazio S, Fogo AB.

    Kidney Int. 2001 May;59(5):1899-910.PMID: 11318962 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Peroxisome proliferator-activated receptor-gamma ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration.

    Goetze S, Kintscher U, Kim S, Meehan WP, Kaneshiro K, Collins AR, Fleck E, Hsueh WA, Law RE.

    J Cardiovasc Pharmacol. 2001 Dec;38(6):909-21.PMID: 11707695 [PubMed - indexed for MEDLINE]Related articles

    20.

    Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma.

    Park KS, Ciaraldi TP, Lindgren K, Abrams-Carter L, Mudaliar S, Nikoulina SE, Tufari SR, Veerkamp JH, Vidal-Puig A, Henry RR.

    J Clin Endocrinol Metab. 1998 Aug;83(8):2830-5.PMID: 9709955 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity